2CI5 image
Deposition Date 2006-03-17
Release Date 2006-05-17
Last Version Date 2024-03-06
Entry Detail
PDB ID:
2CI5
Keywords:
Title:
Crystal structure of Dimethylarginine Dimethylaminohydrolase I in complex with L-homocysteine
Biological Source:
Source Organism:
BOS TAURUS (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
1.79 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:NG, NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1
Gene (Uniprot):DDAH1
Chain IDs:A, B
Chain Length:284
Number of Molecules:2
Biological Source:BOS TAURUS
Primary Citation
Structure of the Mammalian Nos Regulator Dimethylarginine Dimethylaminohydrolase: A Basis for the Design of Specific Inbitors
Structure 14 901 ? (2006)
PMID: 16698551 DOI: 10.1016/J.STR.2006.03.006

Abstact

Dimethylarginine dimethylaminohydrolase (DDAH) is involved in the regulation of nitric oxide synthase (NOS) by metabolizing the free endogenous arginine derivatives N(omega)-methyl-L-arginine (MMA) and N(omega),N(omega)-dimethyl-L-arginine (ADMA), which are competitive inhibitors of NOS. Here, we present high-resolution crystal structures of DDAH isoform 1 (DDAH-1) isolated from bovine brain in complex with different inhibitors, including S-nitroso-L-homocysteine and Zn2+, a regulator of this mammalian enzyme. The structure of DDAH-1 consists of a propeller-like fold similar to other arginine-modifying enzymes and a flexible loop, which adopts different conformations and acts as a lid at the entrance of the active site. The orientation and interaction mode of inhibitors in the active site give insight into the regulation and the molecular mechanism of the enzyme. The presented structures provide a basis for the structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures